APO RESEARCH · REPORT
Piperacillin Sodium
Piperacillin Sodium (CAS 59703-84-3) is the sodium salt of piperacillin, a broad-spectrum semisynthetic, ampicillin-derived ureidopenicillin antibiotic with bactericidal activity.
Product & engineering
Understand the product.
Piperacillin Sodium (CAS 59703-84-3) is the sodium salt of piperacillin, a broad-spectrum semisynthetic, ampicillin-derived ureidopenicillin antibiotic with bactericidal activity.
Selected research
Industry Research
Piperacillin Sodium Industry Research Report 2026
Market perspective
Piperacillin Sodium (CAS 59703-84-3) is the sodium salt of piperacillin, a broad-spectrum semisynthetic, ampicillin-derived ureidopenicillin antibiotic with bactericidal activity.
The classification of Piperacillin Sodium includes Piperacillin Sodium and Piperacillin and Tazobactam. The proportion of Piperacillin and Tazobactam in 2019 is about 78%, and the proportion is in increasing trend from 2015 to 2020.
Piperacillin Sodium is widely used in Piperacillin Sodium Injection and Piperacillin Sodium Compound Injection. The most proportion of Piperacillin Sodium is used in Piperacillin Sodium Compound Injection and the proportion in 2019 is about 86%.
Read the full market overview
China is the largest supply country, it account about 47% of global production in 2019, India is the second largest country with 33% of global share.
Asia-Pacific is the largest consumption market, with a market share nearly 84% in 2019. Following Asia-Pacific, Europe is the second largest consumption market with the market share of 12%.
Qilu Pharmaceutical, Pfizer Healthcare, Fresenius Kabi AG, Aurobindo Pharma, Sandoz Inc, NCPC s, etc. are the leaders of the industry.
Report Scope
This report quantifies the global Piperacillin Sodium market in terms of revenue (US$ million) and, where applicable, sales volume (MT), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/MT) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Piperacillin Sodium Market by Company
Qilu Pharmaceutical
Pfizer Healthcare
Fresenius Kabi AG
Aurobindo Pharma
Sandoz Inc
NCPC
REYOUNG
Yuhan Corporation
LKPC
Nectar Lifesciences
Sterile India
Suanfarma
Rajasthan Antibiotics
Piperacillin Sodium Segment by Type
Piperacillin
Piperacillin and Tazobactam
Piperacillin Sodium Segment by Application
Piperacillin Sodium Injection
Piperacillin Sodium Compound Injection
Piperacillin Sodium Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Piperacillin Sodium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Piperacillin Sodium and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Piperacillin Sodium.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Piperacillin Sodium manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Piperacillin Sodium by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Piperacillin Sodium in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Piperacillin
- Piperacillin and Tazobactam
Applications
- Piperacillin Sodium Injection
- Piperacillin Sodium Compound Injection
Companies covered
- Qilu Pharmaceutical
- Pfizer Healthcare
- Fresenius Kabi AG
- Aurobindo Pharma
- Sandoz Inc
- NCPC
- REYOUNG
- Yuhan Corporation
- LKPC
- Nectar Lifesciences
- Sterile India
- Suanfarma
- Rajasthan Antibiotics
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Piperacillin Sodium Market Size (2021-2032)
- 2.2.2 Global Piperacillin Sodium Sales (2021-2032)
- 2.2.3 Global Piperacillin Sodium Market Average Price (2021-2032)
- 2.3 Piperacillin Sodium by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Piperacillin
- 2.3.3 Piperacillin and Tazobactam
- 2.4 Piperacillin Sodium by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Piperacillin Sodium Injection
- 2.4.3 Piperacillin Sodium Compound Injection
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Piperacillin Sodium Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Piperacillin Sodium Sales (MT) of Manufacturers (2021-2026)
- 3.3 Global Piperacillin Sodium Revenue of Manufacturers (2021-2026)
- 3.4 Global Piperacillin Sodium Average Price by Manufacturers (2021-2026)
- 3.5 Global Piperacillin Sodium Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Piperacillin Sodium, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Piperacillin Sodium, Product Type & Application
- 3.8 Global Manufacturers of Piperacillin Sodium, Established Date
- 3.9 Global Piperacillin Sodium Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Qilu Pharmaceutical
- 4.1.1 Qilu Pharmaceutical Company Information
- 4.1.2 Qilu Pharmaceutical Business Overview
- 4.1.3 Qilu Pharmaceutical Piperacillin Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Qilu Pharmaceutical Piperacillin Sodium Product Portfolio
- 4.1.5 Qilu Pharmaceutical Recent Developments
- 4.2 Pfizer Healthcare
- 4.2.1 Pfizer Healthcare Company Information
- 4.2.2 Pfizer Healthcare Business Overview
- 4.2.3 Pfizer Healthcare Piperacillin Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Pfizer Healthcare Piperacillin Sodium Product Portfolio
- 4.2.5 Pfizer Healthcare Recent Developments
- 4.3 Fresenius Kabi AG
- 4.3.1 Fresenius Kabi AG Company Information
- 4.3.2 Fresenius Kabi AG Business Overview
- 4.3.3 Fresenius Kabi AG Piperacillin Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Fresenius Kabi AG Piperacillin Sodium Product Portfolio
- 4.3.5 Fresenius Kabi AG Recent Developments
- 4.4 Aurobindo Pharma
- 4.4.1 Aurobindo Pharma Company Information
- 4.4.2 Aurobindo Pharma Business Overview
- 4.4.3 Aurobindo Pharma Piperacillin Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Aurobindo Pharma Piperacillin Sodium Product Portfolio
- 4.4.5 Aurobindo Pharma Recent Developments
- 4.5 Sandoz Inc
- 4.5.1 Sandoz Inc Company Information
- 4.5.2 Sandoz Inc Business Overview
- 4.5.3 Sandoz Inc Piperacillin Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Sandoz Inc Piperacillin Sodium Product Portfolio
- 4.5.5 Sandoz Inc Recent Developments
- 4.6 NCPC
- 4.6.1 NCPC Company Information
- 4.6.2 NCPC Business Overview
- 4.6.3 NCPC Piperacillin Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 NCPC Piperacillin Sodium Product Portfolio
- 4.6.5 NCPC Recent Developments
- 4.7 REYOUNG
- 4.7.1 REYOUNG Company Information
- 4.7.2 REYOUNG Business Overview
- 4.7.3 REYOUNG Piperacillin Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 REYOUNG Piperacillin Sodium Product Portfolio
- 4.7.5 REYOUNG Recent Developments
- 4.8 Yuhan Corporation
- 4.8.1 Yuhan Corporation Company Information
- 4.8.2 Yuhan Corporation Business Overview
- 4.8.3 Yuhan Corporation Piperacillin Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Yuhan Corporation Piperacillin Sodium Product Portfolio
- 4.8.5 Yuhan Corporation Recent Developments
- 4.9 LKPC
- 4.9.1 LKPC Company Information
- 4.9.2 LKPC Business Overview
- 4.9.3 LKPC Piperacillin Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 LKPC Piperacillin Sodium Product Portfolio
- 4.9.5 LKPC Recent Developments
- 4.10 Nectar Lifesciences
- 4.10.1 Nectar Lifesciences Company Information
- 4.10.2 Nectar Lifesciences Business Overview
- 4.10.3 Nectar Lifesciences Piperacillin Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Nectar Lifesciences Piperacillin Sodium Product Portfolio
- 4.10.5 Nectar Lifesciences Recent Developments
- 4.11 Sterile India
- 4.11.1 Sterile India Company Information
- 4.11.2 Sterile India Business Overview
- 4.11.3 Sterile India Piperacillin Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Sterile India Piperacillin Sodium Product Portfolio
- 4.11.5 Sterile India Recent Developments
- 4.12 Suanfarma
- 4.12.1 Suanfarma Company Information
- 4.12.2 Suanfarma Business Overview
- 4.12.3 Suanfarma Piperacillin Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Suanfarma Piperacillin Sodium Product Portfolio
- 4.12.5 Suanfarma Recent Developments
- 4.13 Rajasthan Antibiotics
- 4.13.1 Rajasthan Antibiotics Company Information
- 4.13.2 Rajasthan Antibiotics Business Overview
- 4.13.3 Rajasthan Antibiotics Piperacillin Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Rajasthan Antibiotics Piperacillin Sodium Product Portfolio
- 4.13.5 Rajasthan Antibiotics Recent Developments
5 Global Piperacillin Sodium Market Scenario by Region
- 5.1 Global Piperacillin Sodium Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Piperacillin Sodium Sales by Region: 2021-2032
- 5.2.1 Global Piperacillin Sodium Sales by Region: 2021-2026
- 5.2.2 Global Piperacillin Sodium Sales by Region: 2027-2032
- 5.3 Global Piperacillin Sodium Revenue by Region: 2021-2032
- 5.3.1 Global Piperacillin Sodium Revenue by Region: 2021-2026
- 5.3.2 Global Piperacillin Sodium Revenue by Region: 2027-2032
- 5.4 North America Piperacillin Sodium Market Facts & Figures by Country
- 5.4.1 North America Piperacillin Sodium Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Piperacillin Sodium Sales by Country (2021-2032)
- 5.4.3 North America Piperacillin Sodium Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Piperacillin Sodium Market Facts & Figures by Country
- 5.5.1 Europe Piperacillin Sodium Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Piperacillin Sodium Sales by Country (2021-2032)
- 5.5.3 Europe Piperacillin Sodium Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Piperacillin Sodium Market Facts & Figures by Country
- 5.6.1 Asia Pacific Piperacillin Sodium Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Piperacillin Sodium Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Piperacillin Sodium Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Piperacillin Sodium Market Facts & Figures by Country
- 5.7.1 South America Piperacillin Sodium Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Piperacillin Sodium Sales by Country (2021-2032)
- 5.7.3 South America Piperacillin Sodium Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Piperacillin Sodium Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Piperacillin Sodium Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Piperacillin Sodium Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Piperacillin Sodium Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Piperacillin Sodium Sales by Type (2021-2032)
- 6.1.1 Global Piperacillin Sodium Sales by Type (2021-2032) & (MT)
- 6.1.2 Global Piperacillin Sodium Sales Market Share by Type (2021-2032)
- 6.2 Global Piperacillin Sodium Revenue by Type (2021-2032)
- 6.2.1 Global Piperacillin Sodium Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Piperacillin Sodium Revenue Market Share by Type (2021-2032)
- 6.3 Global Piperacillin Sodium Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Piperacillin Sodium Sales by Application (2021-2032)
- 7.1.1 Global Piperacillin Sodium Sales by Application (2021-2032) & (MT)
- 7.1.2 Global Piperacillin Sodium Sales Market Share by Application (2021-2032)
- 7.2 Global Piperacillin Sodium Revenue by Application (2021-2032)
- 7.2.1 Global Piperacillin Sodium Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Piperacillin Sodium Revenue Market Share by Application (2021-2032)
- 7.3 Global Piperacillin Sodium Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Piperacillin Sodium Value Chain Analysis
- 8.1.1 Piperacillin Sodium Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Piperacillin Sodium Production Mode & Process
- 8.2 Piperacillin Sodium Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Piperacillin Sodium Distributors
- 8.2.3 Piperacillin Sodium Customers
9 Global Piperacillin Sodium Analyzing Market Dynamics
- 9.1 Piperacillin Sodium Industry Trends
- 9.2 Piperacillin Sodium Industry Drivers
- 9.3 Piperacillin Sodium Industry Opportunities and Challenges
- 9.4 Piperacillin Sodium Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst